InVivoMAb Anti-MERS-CoV RBD Antibody (S41)

Description: InVivoMAb Anti-MERS-CoV RBD Antibody (S41) [S41] (RA11848) is a human monoclonal antibody detecting Spike glycoprotein in Neutralization.
Host species: Human
Isotype: IgG1, kappa
Species reactivity: Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Form: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Concentration: 1 mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Neutralization
Target: Spike glycoprotein, S glycoprotein, E2, Peplomer protein, RBD, Spike protein S1, S, Receptor-Binding Domain
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: Please contact with the lab for this information.
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Spike glycoprotein (RBD) is a ~149 kDa protein. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. Interacts with host DPP4 to mediate virla entry.
Note: For research use only. Not suitable for clinical or therapeutic use.